OncLive - Clinical Oncology News, Cancer Expert Insights
OncLive - Clinical Oncology News, Cancer Expert Insights
Spotlight
OncClub: Join the Chat on Trending Trials in CancerComplimentary print subscription for home or office deliveryIn-person and virtual events just for HCPsLively expert panel discussions featuring peer-to-peer exchangesSubscribe to our eNewsletter for breaking news and curated content
Specialty
View MoreBreast CancerCAR T-cell TherapyChronic Lymphocytic LeukemiaGastrointestinal CancerGenitourinary CancersGynecologic OncologyImmuno-OncologyLung CancerMelanoma & Skin CancerMultiple MyelomaUrothelial Cancer
News
OncClub
All Oncology News
Pipeline Report
Rare Cancer Series
Media
Insights
Medical World News
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
The Talk
Thoracic Night Live
Conferences
Conference Coverage
Conference Listing
Events
Giants of Cancer Care
PER Events
Scientific Interchanges
State of the Science Summit / IPC
Webinars
Partners
Publications
Oncology Live
Oncology Fellows
Supplements And Featured Publications
All Publications
CME/CE
Resources
Interactive Tools
Learning Modules
Presentations
Sponsored
Subscribe
eNewsletter
Print Subscription
  • Advertise
  • About OncLive
  • Editorial Board
  • CancerNetwork.com
  • CGTlive.com
  • CureToday.com
  • OncNursingNews.com
  • TargetedOnc.com
  • Contact Us
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information

© 2022 MJH Life Sciences and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.

Spotlight
  • OncClub: Join the Chat on Trending Trials in Cancer
  • Complimentary print subscription for home or office delivery
  • In-person and virtual events just for HCPs
  • Lively expert panel discussions featuring peer-to-peer exchanges
  • Subscribe to our eNewsletter for breaking news and curated content
SpecialtySee All >
  • Breast Cancer
  • CAR T-cell Therapy
  • Chronic Lymphocytic Leukemia
  • Gastrointestinal Cancer
  • Genitourinary Cancers
  • Gynecologic Oncology
  • Immuno-Oncology
  • Lung Cancer
  • Melanoma & Skin Cancer
  • Multiple Myeloma
  • Urothelial Cancer
OncLive SOSS
  • Advertise
  • About OncLive
  • Editorial Board
  • CancerNetwork.com
  • CGTlive.com
  • CureToday.com
  • OncNursingNews.com
  • TargetedOnc.com
  • Contact Us
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information
  • MJHLS Brand Logo

2 Clarke Drive
Suite 100
Cranbury, NJ 08512

© 2022 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.

Update on MRD Testing in Acute Lymphoblastic Leukemia

EP. 1: Prognostic Factors in Acute Lymphoblastic Leukemia

February 1st 2020

EP. 2: Considering Induction Regimens for ALL

February 1st 2020

EP. 3: Induction Strategies for Philadelphia-Positive ALL

February 1st 2020

EP. 4: ALL: Cytogenetics and T-Cell Versus B-Cell Induction Strategies

February 1st 2020

EP. 5: Acute Lymphoblastic Leukemia: Optimal Timing of HSCT

February 1st 2020

EP. 6: MRD in ALL: Prognostic Importance and Multidisciplinary Care

February 1st 2020

EP. 7: ALL: When and Who to Test for Minimal Residual Disease

February 1st 2020

EP. 8: Strategies to Assess Minimal Residual Disease

February 1st 2020

EP. 9: Sensitivity of MRD Testing and Impact on Decisionmaking in ALL

February 1st 2020

EP. 10: MRD's Impact on Subsequent Therapy Choice in ALL

February 1st 2020

EP. 11: MRD+ ALL: Evolving Role of BiTE Therapy

February 1st 2020

EP. 12: Optimizing Use of Maintenance Therapy in ALL

February 1st 2020

EP. 13: Future Directions for MRD Testing in ALL

February 1st 2020

EP. 14: MRD Testing in Hematologic Malignancies Other Than ALL

February 1st 2020

EP. 15: Acute Lymphoblastic Leukemia: Future Directions in Therapy

February 1st 2020